This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Under $10 With Big Upside Potential

Ariad Pharmaceuticals

Another under-$10 stock to consider is Ariad Pharmaceuticals (ARIA - Get Report), a biopharmaceutical company focused on the discovery and development of drugs to provide therapeutic intervention in treating human diseases at the cellular level. This stock has been a market leader in 2011, with shares up over 80%.

If you take a look at the chart for Ariad Pharmaceuticals, you'll see that this stock has found big buying support at around $7.50 to $7.70 a share a number of times during the past six months. Every time the stock has hit those levels, it's bounced significantly higher and it has been a great buying opportunity.

Now the stock is approaching some levels that will trigger another big breakout if it can manage to trade above them. The first level to watch is the 50-day moving average at $9.58 a share. The second level is some major overhead resistance at around $10.70 a share. If both of those levels are taken out to the upside in the near future, then I think this stock can make another run at its July highs of $13.50 a share.

>>8 Biotech Stocks to Watch

Market-players should now watch for a breakout for a move above those levels on heavy volume. Look for volume that's tracking in close to or above its three-month average action of 3.86 million shares.

One could be a buyer of this stock on any notable weakness in anticipation of the breakout, or you could just wait for the breakout and then get long off strength. If you buy off weakness I would use a stop just below $9 a share. I would look to add to any long position once this stock takes out $10.70 with volume.

This is another heavily shorted stock with over 12% of the float sold short by the bears. This high short interest could fuel a sizable short-squeeze if we can get back above the 50-day and then above $10.70 in the coming days or weeks.

Ariad shows up on a list of Hot Biotech trades for Second-Half 2011.
5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
ARIA $4.72 0.00%
JVA $3.26 0.00%
NQ $3.26 0.00%
OREX $1.64 0.00%
AAPL $93.99 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs